PEX2 and other peroxins—namely, PEX5, PEX10, and PEX12—play a pivotal role in ensuring the survival of malignant cells and, consequently, emerge as prospective therapeutic targets for combating neoplastic disorders (14). This evidence concerns the gene PEX5 and neoplastic disease or syndrome.